Robert G. Hart

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Apixaban in Patients with Atrial Fibrillation

Stuart J. Connolly, John W. Eikelboom, Campbell Joyner et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

Embolic strokes of undetermined source: the case for a new clinical construct

Robert G. Hart, Hans‐Christoph Diener, Shelagh B. Coutts et al. · The Lancet Neurology · 2014 · 1.6K citations

Cerebrovascular Disease, Neurovascular Disease, Thrombosis +16

Primary Prevention of Ischemic Stroke

Larry B. Goldstein, Robert J. Adams, Mark J. Alberts et al. · Stroke · 2006 · 1.4K citations · Full text